Építés alatt – nem éles oldal
Belépés

NCT07912710Toboroz

China HEalthy Aging and Dementia Study (HEAD)

Forrás: ClinicalTrials.gov · Utoljára frissítve: 2026. nov. 3.

Következő lépések

Rövid összefoglaló (regiszter, angolul)

The China HEalthy Aging and Dementia (HEAD) study is a large-scale, community-based, multi-center prospective cohort study covering eastern, northern, southern, and central-western regions of China. By integrating comprehensive clinical, neuroimaging, biospecimen, and multi-omics data, the study aims to advance the early prediction and diagnosis of Alzheimer's disease and related dementias (ADRD) and provide a foundation for future intervention studies in the Chinese population. The primary aims of the China HEAD study are as follows: 1. To establish a community-based prospective cohort by recruiting over 20,000 participants from eastern, northern, southern, western, and middle regions of China. 2. To build a comprehensive biobank by collecting demographic information, disease history, cognitive function, physical measures, electrophysiologic data, multimodal imaging data, as well as biospecimens and derived multi-omics data. 3. To conduct early prediction and diagnosis studies for ADRD and support future intervention studies based on the above-mentioned cohort and biobank.

Állapot (regiszter)
Toboroz
Vizsgálattípus
Megfigyeléses
Résztvevők száma
20000 (tervezett)
Első benyújtás
2026. okt. 19.
Kezdés
2022. aug. 1.
Elsődleges befejezés
2072. aug. 1.
Fő szponzor
Fudan University
Betegségek
Alzheimer-kór
NCT-szám
NCT07912710

Mit vállalsz

  • Vizsgálat típusa: Megfigyeléses
  • Tervezett résztvevők: 20000
  • 2022. aug. 1. és az elsődleges befejezés (2072. aug. 1.) között
  • 30 helyszín, 1 országban
  • Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket

A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.

Ki nem vehet részt

Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

Más betegség

  • Self-reported stroke events (e.g., cerebral hemorrhage or cerebral infarction) within the past six months.
  • Self-reported diseases potentially impairing cognition, including congenital intellectual disability, intracranial tumors, epilepsy, Parkinson's disease, or severe psychiatric disorders such as schizophrenia requiring medication.
  • Self-reported major organ failure (e.g., liver or kidney failure), malignancy, or other conditions associated with a shortened life expectancy that prevent completion of follow-up assessments.
    • Additional exclusion criteria for participants undergoing magnetic resonance imaging (MRI):
  • Inability to tolerate MRI examinations or contraindications to MRI, including claustrophobia; MRI-incompatible implanted pacemakers, aneurysm clips, artificial heart valves, cochlear implants, or other metallic implants; or other clinical conditions or examination findings that investigators consider potentially harmful during MRI.

Egyéb

  • The following exclusion criteria apply to participants in the HEAD study:
  • Refusal to provide written informed consent.
  • Refusal to participate in questionnaires or other data collection procedures.
  • Refusal to provide blood or other biological samples.

Kiket keres a vizsgálat

  • China HEAD Community Cohort:
  • Resident in a Chinese community.
  • Aged 50-79 years.
  • Have adequate vision and hearing (with glasses or hearing aids if necessary), and be able to walk, communicate, and complete study-related assessments (including questionnaires, physical examinations, neuropsychological assessments, and biospecimen collection) independently or with assistance.
  • Willing to provide written informed consent for baseline assessments, follow-up, biospecimen donation, and data collection.
    • China HEAD Familial Sub-cohort:
  • Resident in a Chinese community.
  • Aged 18 years or older.
  • Have a family history of Alzheimer's disease (AD) involving at least two first-degree relatives across at least two consecutive generations, with AD diagnoses previously established at tertiary hospitals and verified through medical history.
  • Meet the 2011 National Institute on Aging-Alzheimer's Association (NIA-AA) diagnostic criteria for AD.
  • Have adequate vision and hearing (with glasses or hearing aids if necessary), and be able to walk, communicate, and complete study-related assessments (including questionnaires, physical examinations, neuropsychological assessments, and biospecimen collection) independently or with assistance.
  • Willing to provide written informed consent for baseline assessments, follow-up, biospecimen donation, and data collection.

Életkor a regiszterben: 18 év – - · Nem: nők és férfiak · Egészséges önkénteseket is fogad

A teljes feltétellista: ClinicalTrials.gov

Helyszínek (30)

Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.

HelyszínVárosOrszágHelyszín állapota
Peking UniversityBeijingKínaToboroz
Chinese PLA General HospitalBeijingKínaToboroz
Xuanwu Hospital, Capital Medical UniversityBeijingKínaToboroz
Beijing Tiantan Hospital,Capital Medical UniversityBeijingKínaToboroz
Beijing Normal UniversityBeijingKínaToboroz
Beijing University of Posts and TelecommunicationsBeijingKínaToboroz
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical SciencesBeijingKínaToboroz
Peking Union Medical College HospitalBeijingKínaToboroz
Jilin UniversityChangchunKínaToboroz
Sichuan UniversityChengduKínaToboroz
Army Medical University, ChinaChongqingKínaToboroz
Fujian Medical UniversityFuzhouKínaToboroz
Southern Medical UniversityGuangzhouKínaToboroz
Sun Yat-sen UniversityGuangzhouKínaToboroz
The First Affiliated Hospital of University of Science and Technology of ChinaHefeiKínaToboroz
Shandong First Medical UniversityJinanKínaToboroz
Southeast University, ChinaNanjingKínaToboroz
Qingdao UniversityQingdaoKínaToboroz
Ruijin Hospital Shanghai Jiaotong University School of MedicineShanghaiKínaToboroz
Shanghai UniversityShanghaiKínaToboroz
Fudan UniversityShanghaiKínaToboroz
Tongji UniversityShanghaiKínaToboroz
Shenzhen UniversityShenzhenKínaToboroz
Shenzhen Bay LaboratoryShenzhenKínaToboroz
Fudan University Taizhou Institute of Health SciencesTaizhouKínaToboroz
Tianjin Medical UniversityTianjinKínaToboroz
Wuhan University of Science and TechnologyWuhanKínaToboroz
The First Affiliated hospital of Xiamen UniversityXiamenKínaToboroz
Qinghai Provincial People's HospitalXiningKínaToboroz
Zhoukou Central HospitalZhoukouKínaToboroz

Te vagy a koordinátor? Erősítsd meg az adatokat

Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.